Seeking Alpha

Pfizer's (PFE) Zyvox antibiotic was effective in combating a highly drug-resistant and deadly...

Pfizer's (PFE) Zyvox antibiotic was effective in combating a highly drug-resistant and deadly form of tuberculosis called XDR-TB when added to patients' existing treatments. However, 82% of patients experienced side effects such as lower red and while blood cell counts, and damage to the optic and peripheral nerves. The side effects diminished when the drug dose was reduced or ended.
Comments (1)
  • Drew Robertson
    , contributor
    Comments (347) | Send Message
     
    The good news is that you aren't going to die from TB. However there is some bad news but right now I have to take this call. I'll get back to you.
    18 Oct 2012, 10:44 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs